Publications in collaboration with researchers from Hospital Universitario Doctor Peset (51)

2024

  1. Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction

    Antiviral Research, Vol. 231

  2. Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque Psoriasis

    Pharmaceutics, Vol. 16, Núm. 10

  3. Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision Dosing

    Pharmaceutics, Vol. 16, Núm. 12

  4. Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2

2022

  1. IFNγ-Treated Macrophages Induce EMT through the WNT Pathway: Relevance in Crohn’s Disease

    Biomedicines, Vol. 10, Núm. 5

  2. Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis

    Pharmaceutics, Vol. 14, Núm. 3

  3. Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics

    European Journal of Pharmaceutical Sciences, Vol. 174

  4. Quantitative assessment of the exposure–efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 6, pp. 2727-2737

  5. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis

    Biomedicines, Vol. 10, Núm. 3

2021

  1. Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

    Frontiers in Pharmacology, Vol. 12

  2. Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing recommendations

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 3, pp. 905-915

  3. Farmacoterapia personalizada en oncología: Aplicación de criterios farmacocinéticos-farmacodinámicos

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 7, pp. 45-55

  4. Metabolomics as a promising resource identifying potential biomarkers for inflammatory bowel disease

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-25

  5. Physico-Chemical Stability of Admixtures of Vinflunine Used in Clinical Practice

    Journal of Pharmaceutical Sciences, Vol. 110, Núm. 7, pp. 2687-2693

2020

  1. Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development

    Cells, Vol. 9, Núm. 5

  2. WNT2b Activates Epithelial-mesenchymal Transition Through FZD4: Relevance in Penetrating Crohńs Disease

    Journal of Crohn's and Colitis, Vol. 14, Núm. 2, pp. 230-239

2019

  1. Autophagy Stimulation as a Potential Strategy Against Intestinal Fibrosis

    Cells, Vol. 8, Núm. 9

  2. Succinate receptor mediates intestinal inflammation and fibrosis

    Mucosal Immunology, Vol. 12, Núm. 1, pp. 178-187

2018

  1. A single nucleotide polymorphism in the Vitamin D receptor gene is associated with decreased levels of the protein and a penetrating pattern in Crohn's disease

    Inflammatory Bowel Diseases, Vol. 24, Núm. 7, pp. 1462-1470

  2. CD16+ macrophages mediate fibrosis in inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 12, Núm. 5, pp. 589-599